BioSpace News Archive

Swiss pharma giant Novartis supported the company’s Series C financing round with a $75 million equity investment.

Renal cell carcinoma is also called renal cell cancer or renal cell adenocarcinoma. Approximately 90% of all kidney cancers are renal cell carcinomas.

Valid Insight, a leading pharmaceutical global market access consultancy, is one of a select number of businesses to win the esteemed Queen’s Award for Enterprise: International Trade.

Company to build system’s first consolidated services center; new distribution center will house supply chain-related services and non-traditional functions like sterile processing and mail-order pharmacy to drive operational efficiencies

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, will highlight recent Government of Canada actions to address the opioid crisis.

Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets one mutation in their tumor. In a report, published online in Nature Medicine on April 22, 2019, University of California San Diego School of Medicine researchers found that treating patients with personalized, combination therapies improved outcomes in patients with therapy resistant cancers.

GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the publication of a paper in Nature Cell Biology that describes how tumor cells engage specific stromal components, most notably E-selectin, for propagation and outgrowth.

The premier men’s below-the-waist hygiene brand partners with the advocacy group, using humor to boost monthly self-exams and early cancer detection [22-April-2019] SAN DIEGO , April 22, 2019 /PRNewswire/ -- Manscaped , the premier men’s below-the-waist hygiene brand, has partnered with the Testicular Cancer Society to help save lives during Testicular Cancer Aware

Technavio has announced the release of their research report on the global osteoporosis drugs market for the forecast period 2019-2023. This osteoporosis drugs market analysis report segments the market by product (antiresorptive drugs and anabolic drugs) and geography (Asia, Europe, North America, and ROW).

Technavio has announced the release of their research report on the global splenomegaly therapeutics market for the forecast period 2019-2023.